BRISTOL-MYERS SQUIBB COMPANY CORP
Park Avenue 345 – New York – 10154
VAT: nan
http://www.bms.com/landing/data/index.html
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, BRISTOL-MYERS SQUIBB COMPANY CORP has received € 0.0 for its participation in a total of 2 project(s) with a total cost of € 75,938,897.
| Start YYYYMMDD |
End YYYYMMDD |
Project ID | Project Name | Themes | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-04-01 | 2024-03-31 | 821520 | ConcePTION | governance · pharmaceutical drugs · obstetrics · ecosystems | participant | € 0.0 | € 28,657,491 | 3 | 65 | CORDIS ↪ |
| 2017-11-01 | 2023-10-31 | 777377 | LITMUS | drug discovery · diabetes · hepatology · obesity | participant | € 0.0 | € 47,281,406 | 1 | 60 | CORDIS ↪ |
BRISTOL-MYERS SQUIBB COMPANY CORP did not participate in complicit projects under Horizon Europe (2021-2027).
Within the FP7 (2007-2013) framework, BRISTOL-MYERS SQUIBB COMPANY CORP has received € 57,572.0 for its participation in a total of 1 project(s) with a total cost of € 4,874,903.
| Start YYYYMMDD |
End YYYYMMDD |
Project ID | Project Name | Themes | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2011-01-01 | 2014-06-30 | 260600 | GLYCOHIT | biosensors · virology · proteins · oncology · spectroscopy | participant | € 57,572.0 | € 4,874,903 | 1 | 15 | CORDIS ↪ |